Here you go USS --- Dr. Lalezari Aug. 2025 vi
Post# of 157722
(Total Views: 617)
Posted On: 08/28/2025 12:07:51 AM
Re: USS JOHNSTON #156437
Here you go USS ---
Dr. Lalezari [00:18:42] Aug. 2025 video:
And CytoDyn had done three clinical studies in oncology, mostly women with triple negative breast cancer but also other individuals with solid tumors and enrolled 42 patients across three studies during 2020 and 21 and it was right in the teeth of the COVID pandemic.
The past 42...
___
May 16th, 2024 Letter webcast:
Such potential partnerships include an investigator-initiated pilot study of leronlimab in patients with Alzheimer’s Disease,
*20 patients is in one of the 2 webcasts that followed in 2024.
So i pulled it from Google:
" A 20-patient pilot study by CytoDyn for Alzheimer's disease is fully funded by an outside foundation and is set to be conducted at Cornell Medical Center in New York. "
Dec 2024 Letter:
* I am pleased to announce the study is now fully funded by an outside foundation, and the protocol will soon be submitted to both the FDA and the Cornell IRB.
The 20....
___
CRC August 12, 2024:
in combination TAS-102 and bevacizumab in approximately 60 patients with CCR5+, microsatellite stable metastatic CRC (mCRC).
The 60....
___
Past was the 3 pooled trials @ 42 patients.
Current is 2 trials @ 80 patients
Dr. Lalezari [00:18:42] Aug. 2025 video:
And CytoDyn had done three clinical studies in oncology, mostly women with triple negative breast cancer but also other individuals with solid tumors and enrolled 42 patients across three studies during 2020 and 21 and it was right in the teeth of the COVID pandemic.
The past 42...
___
May 16th, 2024 Letter webcast:
Such potential partnerships include an investigator-initiated pilot study of leronlimab in patients with Alzheimer’s Disease,
*20 patients is in one of the 2 webcasts that followed in 2024.
So i pulled it from Google:
" A 20-patient pilot study by CytoDyn for Alzheimer's disease is fully funded by an outside foundation and is set to be conducted at Cornell Medical Center in New York. "
Dec 2024 Letter:
* I am pleased to announce the study is now fully funded by an outside foundation, and the protocol will soon be submitted to both the FDA and the Cornell IRB.
The 20....
___
CRC August 12, 2024:
in combination TAS-102 and bevacizumab in approximately 60 patients with CCR5+, microsatellite stable metastatic CRC (mCRC).
The 60....
___
Past was the 3 pooled trials @ 42 patients.
Current is 2 trials @ 80 patients
(9)
(0)